Determination of reboxetine in rat brain microdialysates and plasma samples using liquid chromatography coupled to fluorescence detection

Naser Shraim, Ralph Clinckers, Sophie Sarre, Yvette Michotte, Ann Van Eeckhaut

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A liquid chromatographic method with fluorescence detection was developed and validated for the quantification of the antidepressant reboxetine (RBX), a selective noradrenalin reuptake inhibitor, in rat brain microdialysates. After modification of the method in terms of sample preparation and sensitivity, it was also validated for the quantification of RBX in rat plasma samples. To enable fluorescence detection, a pre-column derivatization step with 9-fluorenylmethyl chloroformate was included. Separations were performed on a reversed phase C?? column using gradient elution. The retention time for RBX was found to be 8.8 min. The assay of RBX in brain microdialysis samples showed a linear relationship in the calibration curve from 2 to 200 ng/mL, with a correlation coefficient ?0.999. The limit of detection (LOD) and the lower limit of quantification (LLOQ) were 0.6 and 2.0 ng/mL respectively. The intra-day and the inter-day precision (RSD %) ranged between 1.5% and 11.7% with an average recovery of 101.2±8.2% (mean±SD, n=40). For the analysis of plasma samples, the calibration curve was linear between 20 and 700 ng/mL with a correlation coefficient ?0.999. LOD and LLOQ were 6 and 20 ng/mL respectively. The intra-day and the inter-day precision (RSD %) ranged between 1.7% and 11.5% with an average recovery of 98.5±7.3% (mean±SD, n=40). We demonstrated the applicability of the method to determine the concentration-time profiles of RBX in brain and plasma following systemic administration.
Original languageEnglish
Pages (from-to)53-61
JournalJournal of chromatography. B
Volume898
Publication statusPublished - 2012

Keywords

  • Reboxetine, Liquid chromatography

Fingerprint

Dive into the research topics of 'Determination of reboxetine in rat brain microdialysates and plasma samples using liquid chromatography coupled to fluorescence detection'. Together they form a unique fingerprint.

Cite this